
Before starting clinical trials with people, sponsors first study the investigational treatment in the lab on cells or animals. These are called pre-clinical studies. Sponsors must get approval from government regulatory agencies before studying investigational treatments in people. These agencies look at the results from pre-clinical studies and review the sponsor’s plans for the investigational treatment, to decide if it is okay to start clinical trials.